Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Nebivolol Added To Antihypertensive Treatment With Lisinopril or Losartan in Patients With Hypertension.

NCT00734630 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00734630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00734630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Nebivolol Added To Antihypertensive Treatment With Lisinopril or Losartan in Patients With Hypertension.
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2008
Completion date
May 31, 2010
Enrollment
491 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension